We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$5.16B
AUM Growth
-$770M
Cap. Flow
-$830M
Cap. Flow %
-16.07%
Top 10 Hldgs %
43.16%
Holding
126
New
20
Increased
28
Reduced
23
Closed
31

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$280M
2
MNST icon
Monster Beverage
MNST
+$102M
3
HLT icon
Hilton Worldwide
HLT
+$86.3M
4
DECK icon
Deckers Outdoor
DECK
+$83.7M
5
MAR icon
Marriott International
MAR
+$77.7M

Top Sells

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$165M
2
ADBE icon
Adobe
ADBE
+$152M
3
MA icon
Mastercard
MA
+$147M
4
PLAN
Anaplan, Inc.
PLAN
+$132M
5
ROST icon
Ross Stores
ROST
+$122M

Sector Composition

Rank Sector Weight
1 Healthcare 35.24%
2 Consumer Discretionary 21.52%
3 Technology 17.66%
4 Industrials 15.63%
5 Consumer Staples 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
26
Danaher
DHR
$140B
$72.4M 1.4%
+248,386
New +$68.4M
XYZ
27
Block Inc
XYZ
$47.3B
$69.4M 1.34%
429,984
+127,054
+42% +$27.5M
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$65.5M 1.27%
1,251,946
– –
TEL icon
29
TE Connectivity
TEL
$62.1B
$61.7M 1.2%
382,623
-221,254
-37% -$34.2M
NTRA icon
30
Natera
NTRA
$44.7B
$59.4M 1.15%
636,160
-111,060
-15% -$11.5M
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$59.1M 1.14%
402,789
+211,481
+111% +$32.8M
RIVN icon
32
Rivian
RIVN
$22.8B
$52.7M 1.02%
+507,830
New +$58.5M
KURA icon
33
Kura Oncology
KURA
$834M
$50M 0.97%
3,572,419
+1,112,217
+45% +$18M
CPRT icon
34
Copart
CPRT
$26.8B
$46.2M 0.9%
1,220,000
-2,271,056
-65% -$84.3M
FULC icon
35
Fulcrum Therapeutics
FULC
$291M
$42M 0.81%
2,375,571
+433,602
+22% +$8.59M
RARE icon
36
Ultragenyx Pharmaceutical
RARE
$2.59B
$40.8M 0.79%
+485,242
New +$39.5M
AGIO icon
37
Agios Pharmaceuticals
AGIO
$1.92B
$38.7M 0.75%
1,177,374
-134,374
-10% -$5.41M
STRO icon
38
Sutro Biopharma
STRO
$425M
$36.3M 0.7%
243,780
+20,410
+9% +$3.66M
WRBY icon
39
Warby Parker
WRBY
$3.22B
$34.1M 0.66%
733,402
-266,598
-27% -$13.9M
KBR icon
40
KBR
KBR
$4.72B
$32.6M 0.63%
685,500
-2,297,877
-77% -$101M
MRNS
41
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$31.3M 0.61%
2,638,775
+441,349
+20% +$5.1M
EYPT icon
42
EyePoint Inc
EYPT
$1.14B
$30.8M 0.6%
2,519,700
+815,111
+48% +$11M
INSM icon
43
Insmed
INSM
$28.7B
$29.5M 0.57%
1,081,532
+82,800
+8% +$2.37M
ETSY icon
44
Etsy
ETSY
$7.78B
$26.7M 0.52%
+122,158
New +$29.4M
MQ icon
45
Marqeta
MQ
$1.73B
$25.2M 0.49%
+366,842
New +$32.8M
KZR
46
DELISTED
Kezar Life Sciences
KZR
$23.6M 0.46%
140,996
– –
KALV
47
DELISTED
KalVista Pharmaceuticals
KALV
$23.1M 0.45%
1,746,300
+203,016
+13% +$3.23M
ARNA
48
DELISTED
Arena Pharmaceuticals Inc
ARNA
$22.8M 0.44%
245,800
-261,288
-52% -$17.2M
HRTX icon
49
Heron Therapeutics
HRTX
$96.8M
$22.7M 0.44%
2,486,340
+995,900
+67% +$10.2M
XENE icon
50
Xenon Pharmaceuticals
XENE
$6.15B
$21.6M 0.42%
692,000
-466,961
-40% -$14M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Suvretta Capital Management held 126 positions worth $5.16B, down 13% from $5.94B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Suvretta Capital Management withdrew a net $830M in Q4 2021, closing 31 positions and reducing 23 holdings. Its most notable exit was Twilio, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Suvretta Capital Management opened a new position in Microsoft worth $291M.

  • Suvretta Capital Management's largest Q4 2021 buy was Microsoft: 865,000 shares worth $291M.
  • Suvretta Capital Management added most to Analog Devices in Q4 2021, an estimated $60.5M increase.
  • Suvretta Capital Management's biggest Q4 2021 reduction was Adobe, cutting an estimated $152M.
  • Suvretta Capital Management fully exited Twilio in Q4 2021, selling an estimated $165M.
  • Suvretta Capital Management's ten largest holdings make up 43% of its $5.16B portfolio in Q4 2021.
  • Suvretta Capital Management opened 20 new positions and closed 31 in Q4 2021.
  • Suvretta Capital Management's portfolio value fell 13% quarter-over-quarter to $5.16B.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.